| Label-free Femtosecond Laser Imaging Combined With the Fast Lung Artificial Intelligence Model for Rapid Intraoperative Diagnosis of Lung Surgical Specimens: A Multicentre, Prospective, Parallel-workflow, Non-inferiority Study. (NCT07681245) | Shanghai Chest Hospital | 2026-07-03 |
| Segmentectomy Versus Lobectomy for Deep Solid-Dominant Early-Stage NSCLC (NCT07698990) | Shanghai Chest Hospital | 2026-07-01 |
| SYHX2011 in Combination With Carboplatin and Enlonstobart as First-Line Therapy for Squamous Non-Small Cell Lung Cancer (NCT07662811) | Shanghai Chest Hospital | 2026-06-01 |
| Sd-RAB for the Diagnosis of PPNs (NCT06719687) | Shanghai Chest Hospital | 2026-06-01 |
| Xuan Yin Ning Plus Bevacizumab for Malignant Pleural Effusion (NCT07670338) | Shanghai Chest Hospital | 2026-06-01 |
| Robotic-Assisted Bronchoscopy-Guided Synchronous Biopsy and Radiofrequency Ablation for Pulmonary Nodules (NCT07545057) | Shanghai Chest Hospital | 2026-05-01 |
| RATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLC (NCT07541521) | Shanghai Chest Hospital | 2026-04-13 |
| Septum-guided Segmentectomy for Deep Early-stage Lung Cancer (SGS2512) (NCT07564557) | Shanghai Chest Hospital | 2026-04-01 |
| Neoadjuvant Adebrelimab Plus CRT for Locally Advanced Thymic Carcinoma (NCT07479628) | Shanghai Chest Hospital | 2026-04-01 |
| Establishment of a Prospective Clinical Cohort of Small Cell Lung Cancer Patients Receiving Radiotherapy-Involved Comprehensive Treatment (NCT07565532) | Shanghai Chest Hospital | 2026-04-01 |
| Vebreltinib Plus Chemotherapy as First-line Treatment for MET-overexpressing NSCLC (NCT07549061) | Shanghai Chest Hospital | 2026-03-30 |
| Downstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC (NCT07528066) | Shanghai Chest Hospital | 2026-03-02 |
| The Efficacy and Safety of ARNI on the Outcome of Advanced Lung Cancer With Concurrent Hypertension (NCT07261098) | Shanghai Chest Hospital | 2026-01-01 |
| Epicardial Adipose Tissue-Targeted DApagliflozin for Reducing Electrical Remodeling in Atrial Fibrillation (NCT07331727) | Shanghai Chest Hospital | 2026-01-01 |
| Renal Denervation Combined With Pulsed Field Ablation to Prevent Recurrence in Persistent Atrial Fibrillation (NCT07320768) | Shanghai Chest Hospital | 2026-01-01 |
| SGLT2 Inhibitors and Survival in Lung Cancer Patients With Diabetes (NCT07272057) | Shanghai Chest Hospital | 2025-12-07 |
| A Study of SHR-A1811 Combined With Adebelimumab as Neoadjuvant Therapy for Resectable HER2-Altered Non-Small Cell Lung Cancer (NCT07281209) | Shanghai Chest Hospital | 2025-12-01 |
| A Study of QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients With Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy (NCT07091305) | Shanghai Chest Hospital | 2025-10-23 |
| Infiltration Pattern of Locally Advanced ESCC (NCT07567716) | Shanghai Chest Hospital | 2025-10-01 |
| A Study of Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitoring in NSCLC (NCT07058519) | Shanghai Chest Hospital | 2025-09-23 |
| Surufatinib Combined With Chemo Versus Surufatinib in the Treatment of Pulmonary Neuroendocrine Tumors (NCT07357623) | Shanghai Chest Hospital | 2025-09-22 |
| Sleeve Lobectomy Following Neoadjuvant Therapy in NSCLC (NCT07135856) | Shanghai Chest Hospital | 2025-09-01 |
| Clinical Validation Study on the Imaging Efficacy of Mobile 4D CBCT Technology for Peripheral Pulmonary Lesions (NCT07149597) | Shanghai Chest Hospital | 2025-09-01 |
| Novel Thin Bronchoscope Versus Ultrathin Bronchoscope for the Diagnosis of Peripheral Pulmonary Nodules (NCT07135297) | Shanghai Chest Hospital | 2025-09-01 |
| Optimized Ablation of the Posterior Wall in Persistent Atrial Fibrillation (NCT07122336) | Shanghai Chest Hospital | 2025-07-16 |
| A Study of Contrast-enhanced EBUS in Lung Lesions and Intrathoracic Lymph Nodes (NCT07060378) | Shanghai Chest Hospital | 2025-07-10 |
| RAB Versus Ultrathin Bronchoscopy With VBN in the Diagnosis of PPNs (NCT06962436) | Shanghai Chest Hospital | 2025-07-02 |
| Shanghai Clinical Cohort - Esophageal Cancer (NCT07312526) | Shanghai Chest Hospital | 2025-07-01 |
| A Clinical Study on the Efficacy and Safety of the Combination of Limertinib and Bevacizumab Versus Limertinib as First-line Treatment for NSCLC. (NCT06982924) | Shanghai Chest Hospital | 2025-06-30 |
| Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC） (NCT07076693) | Shanghai Chest Hospital | 2025-06-03 |
| Transbronchial MWA for Pulmonary Tumors (NCT06969014) | Shanghai Chest Hospital | 2025-05-12 |
| MWA With or Without Furmonertinib for Early-Stage Non-Small Cell Lung Cancer (NCT06969781) | Shanghai Chest Hospital | 2025-05-01 |
| A Multicenter, Single-arm Phase II Study to Evaluate the Efficacy and Safety of Fulzerasib (IBI351) in Combination With Ivonescimab (AK-112) in First-line Treatment of Advanced or Metastatic Non-small Cell Lung Cancer Patients With KRAS G12C Mutation (NCT06936644) | Shanghai Chest Hospital | 2025-04-30 |
| Cryoablation vs Thoracoscopic Surgery for GGN (NCT06848881) | Shanghai Chest Hospital | 2025-04-20 |
| Resistance Mechanisms and Sequential Treatment Strategies Following First-Line Lorlatinib in ALK-Positive NSCLC (NCT06904547) | Shanghai Chest Hospital | 2025-04-20 |
| GGO-dominant PPLs Diagnosis Using CLE and ssRAB-guided Cryobiopsy (NCT06910046) | Shanghai Chest Hospital | 2025-04-01 |
| EBUS-TTFB vs EBUS-TBNA for Diagnosing Inadequate Lymph Node Specimens Based on MOSE (NCT06913569) | Shanghai Chest Hospital | 2025-04-01 |
| Neoadjuvant Chemotherapy Sequentially Combined with Sintilimab in Resectable EGFR-Mutant NSCLC (NCT06688656) | Shanghai Chest Hospital | 2025-03-31 |
| Intracardiac Echocardiography-Guided Catheter Ablation for Premature Ventricular Contractions Originating From the Papillary Muscles (NCT06898281) | Shanghai Chest Hospital | 2025-03-23 |
| Efficacy of Mavacamten Combined With Radiofrequency Ablation in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (NCT06856265) | Shanghai Chest Hospital | 2025-02-26 |
| Efficacy and Safety of Pulsed Field Ablation in Refractory Mitral Isthmus-dependent Atrial Flutter: Pulsed Field Ablation Vs. Radiofrequency Ablation: a Preliminary Randomized Controlled Study (NCT06850064) | Shanghai Chest Hospital | 2025-02-24 |
| The Effect of Toripalimab Plus Radiotherapy in Patients With Operable Stage II-IIIA (N+) Non Small Cell Lung Cancer (NCT05798845) | Shanghai Chest Hospital | 2025-02-20 |
| Comparative Efficacy and Safety of Extensive Electro-Anatomical Guided Pulsed Field Ablation Versus Radiofrequency Ablation in Persistent Atrial Fibrillation (NCT06745167) | Shanghai Chest Hospital | 2025-01-01 |
| Pulsed Field Ablation in Three Different Substrate Ablation Strategies for Persistent Atrial Fibrillation (NCT06739512) | Shanghai Chest Hospital | 2024-12-25 |
| Atrial Fibrillation with Heart Failure with Preserved Ejection Fraction: Treatment Strategies-Catheter Ablation Vs. Anti-Atrial Arrhythmia Drugs (NCT06740539) | Shanghai Chest Hospital | 2024-12-16 |
| Efficacy and Safety of Intravenous + Oral Vs. Oral Amiodarone in Preventing Recurrence After Catheter Ablation in Patients with Persistent Atrial Fibrillation (NCT06742866) | Shanghai Chest Hospital | 2024-12-16 |
| A Single-Arm, Phase Ⅰb Study of Golidocitinib Combined With Anti-PD-1 for the Treatment of Previously Treated NSCLC (NCT06690671) | Shanghai Chest Hospital | 2024-12-15 |
| Intrathecal Injection Pemetrexed And Bevacizumab in Patients With Leptomeningeal Metastases in NSCLC (NCT06663306) | Shanghai Chest Hospital | 2024-12-09 |
| Perioperative Tislelizumab for Resectable II-IIIB(N2) KRAS-mutated Nonsquamous Non-small Cell Lung Cancer (NCT06659042) | Shanghai Chest Hospital | 2024-11-20 |
| Perioperative Treatment Outcomes of Early NSCLC (NCT06610240) | Shanghai Chest Hospital | 2024-11-01 |
| A Phase II Clinical Study of Sintilimab Combined with Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC) (NICE-CS) (NCT06709417) | Shanghai Chest Hospital | 2024-11-01 |
| Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and Carboplatin (NCT06698965) | Shanghai Chest Hospital | 2024-10-13 |
| Optimized Posterior Left Atrial Wall Ablation Strategy for PeAF (NCT06633523) | Shanghai Chest Hospital | 2024-10-01 |
| Efficacy and Safety of Combination Therapy of Sintilimab and Chemotherapy With Cryoablation in NSCLC (NCT06483009) | Shanghai Chest Hospital | 2024-10-01 |
| Neoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients(neoR-TORCH) (NCT06437977) | Shanghai Chest Hospital | 2024-09-12 |
| Assessment the Effectiveness of BTVA in COPD and Ablation in Pulmonary Nodules by Pulmonary MRI (NCT07045532) | Shanghai Chest Hospital | 2024-09-01 |
| Cryoablation with or Without Serplulimab in Treating Patients with Stage I-IIA Non-small Cell Lung Cancer (NCT06580665) | Shanghai Chest Hospital | 2024-09-01 |
| Real-World Assessment of Therapeutic Strategies and Survival Outcomes Following First-Line Tislelizumab Therapy in Advanced Non-Small Cell Lung Cancer (NCT06962449) | Shanghai Chest Hospital | 2024-08-16 |
| Augmented Reality Assisted Lung Nodule Localization: a Multicentered, Prospective, Randomly Controlled, Non-inferiority Trial (NCT06548451) | Shanghai Chest Hospital | 2024-08-15 |
| Trametinib Plus Anlotinib Combined With Tislelizumab in KRAS-mutant NSCLC (NCT06456138) | Shanghai Chest Hospital | 2024-07-01 |
| Neoadjuvant Immunochemotherapy for Adenocarcinoma of the Esophagogastric Junction (NCT06469060) | Shanghai Chest Hospital | 2024-06-19 |
| Neoadjuvant PD-1 Blockade for Elderly Esophageal Squamous Cell Carcinoma (BLESS) (NCT06385730) | Shanghai Chest Hospital | 2024-06-17 |
| A Comparative Study Evaluating the Vein of MArshall Ethanol Infusion Ablation Using an Over-the-wire (OTW) Balloon Versus a microcatHeter in Patients With Atrial Fibrillation (NCT06460831) | Shanghai Chest Hospital | 2024-06-15 |
| Optical Biopsy for Peripheral Pulmonary Lesions (NCT06457087) | Shanghai Chest Hospital | 2024-06-01 |
| Toripalimab Combined With Cryoablation for First-line Oligo-progression in Driver-negative Advanced NSCLC (NCT06127303) | Shanghai Chest Hospital | 2024-04-02 |
| Prediction of Anastomotic Complications and Recurrent Laryngeal Nerve Injury Based on Postoperative Early Endoscopic Evaluation (NCT06348381) | Shanghai Chest Hospital | 2024-04-01 |
| Improving Patient-reported Outcomes After Lung Cancer Surgery With Mobile Internet Platform (NCT06483295) | Shanghai Chest Hospital | 2024-03-24 |
| The Novel Special Light for Endotracheal/Bronchial Lesions. (NCT07036614) | Shanghai Chest Hospital | 2024-01-31 |
| Blinded Randomized Controlled Trial of Artificial Intelligence Guided Detection of Intracardiac Thrombus (NCT06206187) | Shanghai Chest Hospital | 2024-01-05 |
| Transthoracic vs Transbronchial Radiofrequency Ablation for Lung Cancer (NCT06503744) | Shanghai Chest Hospital | 2024-01-04 |
| RAE Versus MIE in Patients With Esophageal Cancer After Neoadjuvant Therapy (NCT06012214) | Shanghai Chest Hospital | 2024-01-01 |
| A Multi-center RCT to Evaluate Subsegmental BTVA Treatment for Severe Emphysema (NCT06152107) | Shanghai Chest Hospital | 2024-01-01 |
| Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) Scan (NCT06358222) | Shanghai Chest Hospital | 2023-12-15 |
| Neoadjuvant Adebrelimab Plus Chemotherapy for Resectable ESCC: a Single Arm, Prospective Phase 2 Clinical Trial (NCT06178211) | Shanghai Chest Hospital | 2023-12-01 |
| Glycoprotein in Immunotherapy Response and Efficacy Prediction of Lung Cancer (NCT06730503) | Shanghai Chest Hospital | 2023-10-01 |
| A Randomized Controlled Study of Ablation Pursuing Atrial Fibrillation Termination as a Procedural Endpoint in Patients With Persistent Atrial Fibrillation (NCT05921734) | Shanghai Chest Hospital | 2023-08-01 |
| Pembrolizumab Plus Bevacizumab and Chemotherapy for Non-Squamous NSCLC Patients (NCT05751187) | Shanghai Chest Hospital | 2023-06-27 |
| Application of Mixed Reality Technique for Percutaneous Lung Nodule Localization: A Prospective, Randomized, Controlled Trial (NCT05715996) | Shanghai Chest Hospital | 2023-05-23 |
| A Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLC (NCT06443684) | Shanghai Chest Hospital | 2023-05-08 |
| Cadonilimab in Patients (Pts) With Advanced Non-small Cell Lung Cancer (NSCLC) (NCT05816499) | Shanghai Chest Hospital | 2023-02-16 |
| Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer (NCT06173986) | Shanghai Chest Hospital | 2023-01-10 |
| Left Atrial Isolation by Catheter Ablation in Persistent Atrial Fibrillation With Severe Atrial Fibrosis (NCT05173779) | Shanghai Chest Hospital | 2023-01-01 |
| Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma (NCT05978193) | Shanghai Chest Hospital | 2023-01-01 |
| PerAF: AF Termination vs Prespecified Ablation (NCT06837441) | Shanghai Chest Hospital | 2023-01-01 |
| Camrelizumab Combined With Neoadjuvant Concurrent Chemoradiotherapy for Resectable Locally Advanced ESCC（NICE-RT） (NCT05650216) | Shanghai Chest Hospital | 2022-12-25 |
| Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced Esophageal Squamous Cell Cancer (RICE) (NCT05621707) | Shanghai Chest Hospital | 2022-11-02 |
| First-line Treatment With Dacomitinib Plus Anlotinib for Patients With Advanced NSCLC With EGFR 21L858R Mutations (NCT05271916) | Shanghai Chest Hospital | 2022-10-13 |
| Electroacupuncture Intervention in Catheter Ablation of Atrial Fibrillation (NCT05575544) | Shanghai Chest Hospital | 2022-10-11 |
| Induction Chemoimmunotherapy in Combination With Chemoradiotherapy and Consolidation Immunotherapy in Unresectable Locally Advanced Non-Small Cell Lung Cancer (NCT07632365) | Shanghai Chest Hospital | 2022-10-09 |
| Feasibility of Thin Cp-EBUS Scope BF-UC290F for the Diagnosis of PPLs (NCT05512533) | Shanghai Chest Hospital | 2022-09-02 |
| Comparison of Peri-procedural Complications of Intracardiac Echocardiography and Transesophageal Echocardiography in Patients With Atrial Fibrillation (NCT05466266) | Shanghai Chest Hospital | 2022-08-01 |
| Exosomes Detection for the Prediction of the Efficacy and Adverse Reactions of Anlotinib in Patients With Advanced NSCLC (NCT05218759) | Shanghai Chest Hospital | 2022-02-21 |
| Augmented Reality-assisted Localization of Solitary Pulmonary Nodules for Precise Sublobar Lung Resection (NCT05162235) | Shanghai Chest Hospital | 2022-01-01 |
| China Lung Cancer Screening (CLUS) Study Version 3.0 (NCT05494021) | Shanghai Chest Hospital | 2022-01-01 |
| Recurrent Persistent Atrial Fibrillation:In-situ Ablation Vs Extensive Ablation (NCT06829446) | Shanghai Chest Hospital | 2022-01-01 |
| SHR-1701 for Consolidation Therapy After Concurrent Chemoradiotherapy in Inoperable Stage III NSCLC (NCT05177497) | Shanghai Chest Hospital | 2022-01-01 |
| Sintilimab Combined With Anlotinib for Perioperative Non-small Cell Lung Cancer Based on MRD Evaluation (NCT05460195) | Shanghai Chest Hospital | 2022-01-01 |
| Evaluate the Diagnostic Value of BTPNA for PPL: a Real-world Study (NCT04597346) | Shanghai Chest Hospital | 2021-12-23 |
| Catgut Embedding in Acupoints on Treating Persistent Atrial Fibrillation After Catheter Ablation (NCT05125042) | Shanghai Chest Hospital | 2021-12-01 |
| Catheter Ablation and Surgical Ablation of Persistent Atrial Fibrillation With Severe Atrial Fibrosis (NCT05153486) | Shanghai Chest Hospital | 2021-12-01 |